1-9 of 9
Authors: Mary Scott Roberts
Journal Article
9295 Characteristics Of Adults with Autosomal Dominant Hypocalcemia Type 1 (ADH1) Enrolled In The CLARIFY Disease Monitoring Study
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.383, https://doi.org/10.1210/jendso/bvae163.383
Published: 05 October 2024
Journal Article
OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629)
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.561, https://doi.org/10.1210/jendso/bvad114.561
Published: 05 October 2023
Journal Article
SAT231 Next-generation Sequencing For Detection Of Underlying Genetic Causes Of Nonsurgical Hypoparathyroidism: Preliminary Results From A Sponsored Testing Program
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.527, https://doi.org/10.1210/jendso/bvad114.527
Published: 05 October 2023
Journal Article
OR21-2 Encaleret (CLTX-305) Restored Mineral Homeostasis in a Phase 2 Study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A193–A194, https://doi.org/10.1210/jendso/bvac150.399
Published: 01 November 2022
Journal Article
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience
Journal of the Endocrine Society, Volume 5, Issue 9, September 2021, bvab099, https://doi.org/10.1210/jendso/bvab099
Published: 02 June 2021
Journal Article
Burosumab Provides Sustained Improvement in Phosphorus Homeostasis and Heals Rickets in Children Aged 1 to 4 Years With X-Linked Hypophosphatemia (XLH)
Journal of the Endocrine Society, Volume 5, Issue Supplement_1, April-May 2021, Page A251, https://doi.org/10.1210/jendso/bvab048.511
Published: 03 May 2021
Journal Article
X-Linked Hypophosphatemia: A New Era in Management
Journal of the Endocrine Society, Volume 4, Issue 12, December 2020, bvaa151, https://doi.org/10.1210/jendso/bvaa151
Published: 14 October 2020
Journal Article
OR29-06 Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome
Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020, OR29-06, https://doi.org/10.1210/jendso/bvaa046.403
Published: 08 May 2020
Journal Article
SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)
Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020, SUN-356, https://doi.org/10.1210/jendso/bvaa046.196
Published: 08 May 2020
